Academic
Publications
Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu,10.1016/j.ijgo.2008.04.008,International Jo

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu   (Citations: 10)
BibTex | RIS | RefWorks Download
ObjectiveTo study the effect of trastuzumab in patients with progressive or recurrent metastatic endometrial carcinoma shown by immunohistochemistry to overexpress the HER2/neu receptor.
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: